University of Vigo
Pontevedra, 36004, Spain
NCT Number: NCT05184608
Taking into account the process of functional and cognitive evolution that patients with Parkinson's disease experience throughout the evolution of the pathology, the objective of this study is to evaluate the effect of a dual-task program combining cognitive tasks and forced cycling on the functional and cognitive capacity of these patients.
Looking for future studies?
Notify MeAll sexes
Interventional
Not applicable
Pontevedra, 36004, Spain
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
20 minutes of cycling (90 rpm).
20 minutes of cognitive tasks based on the different domains of the UPDRS scale.
Time frame: Change from Baseline Timed Up and Go at 7 weeks
Dynamic balance
Time frame: Change from Baseline Sit to Stan Test at 7 weeks
Lower limbs strength
Time frame: Change from Baseline Unified Parkinson's Disease Rating Scale at 7 weeks (0-159, better lower values)
Parkinson's Disease rating
Time frame: Change from Baseline Parkinson's Disease Questionnaire - 39 at 7 weeks (0-100, better lower values)
Quality of life
Time frame: Change from Baseline Trail Making Test A & B at 7 weeks
Attention, visual screening ability and processing speed
Time frame: Change from Baseline Stroop Test at 7 weeks
Ability to inhibit cognitive interference
University of Vigo
Other
Effects of a Cycling Dual-task Intervention on Cognition and Functionality in Parkinson's Disease: a Pilot Randomized Clinical Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06133283
Basal Ganglia Diseases, Brain Diseases
San Antonio, Texas, United States
View Trial DetailsNCT05766813
Basal Ganglia Diseases, Brain Diseases
Phoenix, Arizona, United States
View Trial DetailsNCT07723027
Basal Ganglia Diseases, Brain Diseases
Shakargarh, Punjab Province, Pakistan
View Trial DetailsNCT07361250
Basal Ganglia Diseases, Brain Diseases
Wuhan, Hubei, China
View Trial Details